Google said Friday it was banning online ads for unproven medical treatments including most stem cell and gene therapy.
"This new policy will prohibit ads selling treatments that have no established biomedical or scientific basis," Google policy adviser Adrienne Biddings said in a blog post.
Biddings said Google will "prohibit advertising for unproven or experimental medical techniques such as most stem cell therapy, cellular (non-stem) therapy and gene therapy." Google will also ban "treatments that are rooted in basic scientific findings and preliminary clinical experience, but currently have insufficient formal clinical testing to justify widespread clinical use," she added.
The online giant said it made the decision due to "a rise in bad actors attempting to take advantage of individuals by offering untested, deceptive treatments." The company said this was not an effort to diminish the importance of medical discoveries but maintained that "monitored, regulated clinical trials are the most reliable way to test and prove important medical advances." Google said it took the action after consulting experts in the field and that its move was endorsed by the president of the International Society for Stem Cell Research, Deepak Srivastava.
In Google's statement, Srivastava was quoted as saying, "The premature marketing and commercialization of unproven stem cell products threatens public health, their confidence in biomedical research, and undermines the development of legitimate new therapies." Online services have struggled to filter out misleading and deceptive content, including medical hoaxes, while remaining open platforms.
Earlier this year Facebook and Google-owned YouTube moved to reduce the spread of misleading health care claims after a media report showed the proliferation of bogus cancer cures on social media.
Facebook said it made changes as part of efforts to reduce the spread of misleading medical claims including from groups opposing the use of recommended vaccines.
A Wall Street Journal report, based on interviews with doctors, lawyers, privacy experts and others, found numerous false or misleading claims about cancer therapies online.
These included videos advocating the use of potentially dangerous cell-killing ointments, unverified dietary regimes, or unapproved screening techniques.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
